# US 6,559,132 B1 · Composition comprising heparin as a non-thrombogenic surface coating agent

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 6,559,132 B1
- Document ID: US6559132B1
- Status: Granted
- Kind: B1
- Application number: 09/763,856
- Filed: 2001-02-27
- Granted: 2003-05-06
- Earliest claimed: 1998-09-09
- Assignees: Carmeda AB
- Inventors: Erik Holmer
- Web page: https://patentgrep.com/patent/US6559132B1

## CPC

- A61L 33/0029: {using an intermediate layer of polymer}
- C08B 37/0078: {Degradation products}
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)
- C08B: POLYSACCHARIDES; DERIVATIVES THEREOF (polysaccharides containing less than six saccharide radicals attached to each other by glycosidic linkages C07H; fermentation or enzyme-using processes C12P19/00; sugar industry C13; production of cellulose D21)

## Abstract

The present invention relates to a composition comprising heparin to be used as a non-thrombogenic surface when in contact with arterial blood flow. It also relates to a device treated on the surface thereof with such a composition.

## Claims

### Claim 1

A method of use for preparing a non-thrombogenic surface for preventing formation of arterial thrombosis comprising:
using heparin enriched with respect to high affinity, HA, heparin.

### Claim 2

A method of use for preparing a non-thrombogenic surface for preventing formation of arterial thrombosis comprising:
using heparin enriched with respect to high affinity, HA, heparin, coupled to a surface.

### Claim 3

A method of use for preparing a non-thrombogenic surface for preventing formation of arterial thrombosis comprising:
using a composition containing heparin enriched with respect to high affinity, HA, heparin, coupled to a surface, together with a suitable carrier.

### Claim 4 (depends on 1)

A method of use according to claim 1, wherein the high affinity, HA, heparin is purified.

### Claim 5 (depends on 1)

A method of use according to claim 1, wherein the high affinity, HA, heparin is coupled to a surface by end point attachment.

### Claim 6 (depends on 3)

A method of use according to claim 3, wherein the carrier is selected from the group of organic compounds having functional groups such as amino, aldehydo, hydroxyl, carboxylic acid, carbodiimido or other reactive functional groups that can be bound to functional groups present in or introduced into the heparin, and wherein the functional compounds can be low molecular weight compounds or polymers.

### Claim 7 (depends on 6)

A method of use according to claim 6, wherein the low molecular weight compounds or polymers are selected from the group of tridodecylmethylammonium chloride, benzalkonium chloride derivatives, ethyl dimethylaminopropyl carbodiimide, glutaraldehyde, polyamines, polyethylenimine (PEI), polylysine, polycarboxylic acids, polyacrylic acid, polyalcohols, polyvinyl alcohol, polysaccharides and combinations thereof.

### Claim 8 (depends on 1)

A method of use according to claim 1, further comprising:
treating a surface of a device with a composition comprising said heparin enriched with high affinity, HA, heparin.

### Claim 9 (depends on 8)

A method of use according to claim 8, wherein the device is selected from the group consisting of stents, grafts, stent-grafts, catheters, heart-valves, filters, tubings and membrane containing devices.
